Although the site is currently operated by a single writer, we hold ourselves to the same standards outlined below on every piece we publish.
Sourcing & fact-checking
Every article begins with thorough research, drawing from credible sources such as peer-reviewed studies, clinical trial data, official guidelines, and expert opinions in the healthcare field. Every claim is checked against reliable evidence before publication.
Industry reports and direct communication with thought leaders, including healthcare professionals, help validate the data presented in our coverage.
Original reporting
All content published on On The Pen is original and written from a patient-centric perspective — relatable, insightful, and reflective of the latest developments in GLP-1 treatments and obesity management.
News coverage and opinion pieces are kept clearly distinguished from one another, with a focus on giving readers actionable information.
Transparency & authorship
Every article is authored by Dave Knapp, the founder of On The Pen. Maintaining transparency in authorship means readers always know the source of the information they're reading, and that it reflects both subject-matter familiarity and personal experience.
Content is regularly updated to reflect new research findings, FDA approvals, or changes in treatment protocols.
Editorial independence
On The Pen maintains strict editorial independence, with no influence from external advertisers or sponsors. While partnerships may occur, editorial decisions are made solely based on the value and relevance of the content to our audience.
We operate with a commitment to inclusivity and empathy, focused on reducing the stigma around obesity and promoting a well-rounded understanding of GLP-1 medications.
Sponsorships and affiliate partnerships never influence our editorial coverage or opinions — see our full sponsorship disclosures for every current partner.
Corrections
Should any factual errors be identified, On The Pen adheres to a transparent corrections policy. Mistakes are promptly corrected, and updates are clearly noted so readers always have access to the most accurate, current information.
Feedback & community input
On The Pen values community input, encouraging readers to share their personal experiences, which can be incorporated into future coverage to provide a fuller picture of living with obesity and managing diabetes through GLP-1 medications.
Reader feedback and suggestions are taken seriously in shaping future coverage — reach out any time via our contact page.